NGL FINE-CHEM LTD.
Smart Quotes
Trade Value (Rs. in Lacs) | 0.00 |
Dividend Yield(%) | 0.07 |
TTM EPS (Rs.) | 58.59 |
P/E Ratio | 43.48 |
Book Value (Rs.) | 407.79 |
Face Value (Rs.) | 5 |
MCap (Rs. in Mn) | 15739.13 |
Price/Earning (TTM) | 35.61 |
Price/Sales (TTM) | 5.14 |
Price/Book (MRQ) | 6.25 |
PAT Margin (%) | 7.31 |
ROCE (%) | 11.50 |
Management Info :
- Chairman Rahul J Nachane - Managing DirectorRegistered Office :
Address :
301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057
Phone : 022 26636450
Email : info@nglfinechem.com
Website : www.nglfinechem.com
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale..
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale..
Inter alia to consider and approve: (1) Appointment of Mr. Dha..
QTR Dec 23 | ANNUAL 23 | |
---|---|---|
Net Profit | 88.96 | 201.19 |
Gross Profit | 127.96 | 266 |
Operating Profit | 151.38 | 356.96 |
Net Sales | 848.12 | 2750.52 |
Neuland Laboratories (BSE)  7600.75 (5.52%) | M.Cap ( in Cr) 9751.68 |
Procter&Gamble Healt (BSE)  4916.35 (2.97%) | M.Cap ( in Cr) 8160.84 |
Abbott India (BSE)  26415.75 (0.53%) | M.Cap ( in Cr) 56131.62 |
Pfizer (BSE)  4253.30 (1.13%) | M.Cap ( in Cr) 19457.88 |
Sanofi India (BSE)  8324.10 (0.51%) | M.Cap ( in Cr) 19170.92 |
|
PROMOTERS | 72.74 % |
|
NON-INSTITUTION | 27.16 % |
|
MUTUAL FUNDS/UTI | 0 % |
|
FI/BANKS/INSURANCE | 0 % |
|
GOVERNMENT | 0 % |
|
FII | 0 % |
Scheme Name | Hold(%) |
---|---|
Motilal Oswal S&P BSE H... | 0.03 |